MediMabBio

Seongnam, South Korea

MediMabBio is a biotherapeutic company that focuses on the generation of novel immunotherapies for the treatment of cancer.

$17.8M raised

Oct 2025

Series B

Top Investors

HLB BiostepKB InvestmentYuanta InvestmentSeoul Investment PartnersSmilegate Investment

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has MediMabBio raised?

MediMabBio has raised $17.8M in total funding. The most recent round was Series B. The last funding was announced in October 2025.

Who are MediMabBio's investors?

MediMabBio's investors include HLB Biostep, KB Investment, Yuanta Investment, Seoul Investment Partners, Smilegate Investment.

Where is MediMabBio headquartered?

MediMabBio is headquartered in Seongnam, South Korea.

What does MediMabBio do?

MediMabBio is a biotherapeutic company that focuses on the generation of novel immunotherapies for the treatment of cancer.

What stage is MediMabBio at?

MediMabBio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 24, 2025.

MLA

"MediMabBio — Funding & Investors." VCBacked, October 24, 2025, https://www.vcbacked.co/company/medimabbio. Accessed June 3, 2026.

APA

VCBacked. (2025). MediMabBio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/medimabbio

Wikipedia (cite web)

{{cite web |title=MediMabBio — Funding & Investors |url=https://www.vcbacked.co/company/medimabbio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 24, 2025.